IOBT: IO Biotech, Inc. Stock

by  •  • Comments Off on IOBT: IO Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 54.62
Enterprise Value ($M) -25.57
Book Value ($M) 72.56
Book Value / Share 1.10
Price / Book 0.75
NCAV ($M) 68.86
NCAV / Share 1.05
Price / NCAV 0.79

Profitability (mra)
Return on Invested Capital (ROIC) -1.21
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.68

Liquidity (mrq)
Quick Ratio 5.37
Current Ratio 5.37

Balance Sheet (mrq) ($M)
Current Assets 86.24
Assets 89.94
Liabilities 17.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-13 13G/A Stonepine Capital Management, LLC 0.00 -100.00
09-17 13D/A Novo Holdings A/S 8.50 -15.58
02-14 13G/A Avoro Capital Advisors LLC 0.00 -100.00
02-13 13G/A Bank Of America Corp /de/ 2.80 -0.54
02-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 6.00 -28.59
2023-12-18 13G Samsara BioCapital, L.P. 5.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-22 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 18,618 150,923 12.34
2025-01-14 35,592 105,811 33.64
2025-01-13 25,786 128,669 20.04
2025-01-10 23,007 167,975 13.70

(click for more detail)

Similar Companies
INSM – Insmed Incorporated INVA – Innoviva, Inc.
INZY – Inozyme Pharma, Inc. IONS – Ionis Pharmaceuticals, Inc.
IPSC – Century Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io